Stay updated on Etripamil Nasal Spray Safety Study Clinical Trial
Sign up to get notified when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.

Latest updates to the Etripamil Nasal Spray Safety Study Clinical Trial page
- CheckyesterdayNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

- Check29 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, indicating a newer release. No other substantive content changes detected.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded a Publications section with a PubMed-listed study (Etripamil Nasal Spray for recurrent PSVT, NODE-303; online ahead of print Sep 11, 2025) and updated the revision to v3.0.2. Removed the older v3.0.1 revision and the Back to Top link.SummaryDifference3%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has undergone significant updates, including the addition of multiple facility names and locations across Argentina, Brazil, and Canada, while also removing several previously listed locations and terms. The revision number has been updated to v3.0.0.SummaryDifference4%

- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Etripamil Nasal Spray Safety Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.